Status:
COMPLETED
Evaluation of Blood Loss During Knee Arthroplasty
Lead Sponsor:
Groupe Hospitalier Diaconesses Croix Saint-Simon
Conditions:
Primary Knee Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary arthroplasties are frequent interventions that can present hemorrhagic complications: postoperative hematoma, deglobulization justifying monitoring blood tests and blood transfusion if necessa...
Detailed Description
After obtaining the patient's consent and randomisation, the operating surgeon will have the information of placing or not a drain, lately at the end of the intervention so that the course of the inte...
Eligibility Criteria
Inclusion
- Patient consent
- Patient aged over 18 years
- Patient scheduled for primary knee arthroplasty
Exclusion
- Patient expresses his/her opposition to participating in the study
- Patient scheduled for revision, revision or totalization arthroplasty
- Primary arthroplasty after septic arthritis
- Patient requiring an additional planned or unplanned surgical procedure such as TTTA, osteosynthesis for an intraoperative fracture and/or removal of material
Key Trial Info
Start Date :
April 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2023
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT06052982
Start Date
April 10 2022
End Date
July 10 2023
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, Île-de-France Region, France, 75020